Literature DB >> 12402327

Hepatitis B surface antigen (HBsAg) expression in plant cell culture: Kinetics of antigen accumulation in batch culture and its intracellular form.

Mark L Smith1, Hugh S Mason, Michael L Shuler.   

Abstract

The production of edible vaccines in transgenic plants and plant cell culture may be improved through a better understanding of antigen processing and assembly. The hepatitis B surface antigen (HBsAg) was chosen for study because it undergoes substantial and complex post-translational modifications, which are necessary for its immunogenicity. This antigen was expressed in soybean (Glycine max L. Merr. cv Williams 82) and tobacco NT1 (Nicotiana tabacum L.) cell suspension cultures, and HBsAg production in batch culture was characterized. The plant-derived antigen consisted predominantly of disulfide cross-linked HBsAg protein (p24(s)) dimers, which were all membrane associated. Similar to yeast, the plant-expressed HBsAg was retained intracellularly. The maximal HBsAg titers were obtained with soybean suspension cultures (20-22 mg/L) with titers in tobacco cultures being approximately 10-fold lower. For soybean cells, electron microscopy and immunolocalization demonstrated that all the HBsAg was localized to the endoplasmic reticulum (ER) and provoked dilation and proliferation of the ER network. Sucrose gradient analysis of crude extracts showed that HBsAg had a complex size distribution uncharacteristic of the antigen's normal structure of uniform 22-nm virus-like particles. The extent of authentic epitope formation was assessed by comparing total p24(s) synthesized to that reactive by polyclonal and monoclonal immunoassays. Depending on culture age, between 40% and 100% of total p24(s) was polyclonal antibody reactive whereas between 6% and 37% was recognized by a commercial monoclonal antibody assay. Possible strategies to increase HBsAg production and improve post-translational processing are discussed. Copyright 2002 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12402327     DOI: 10.1002/bit.10444

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  12 in total

Review 1.  Virus-like particles production in green plants.

Authors:  Luca Santi; Zhong Huang; Hugh Mason
Journal:  Methods       Date:  2006-09       Impact factor: 3.608

2.  Enhanced heterologous expression of biologically active human granulocyte colony stimulating factor in transgenic tobacco BY-2 cells by localization to endoplasmic reticulum.

Authors:  Nisha R Nair; M Chidambareswaren; S Manjula
Journal:  Mol Biotechnol       Date:  2014-09       Impact factor: 2.695

3.  On the way to commercializing plant cell culture platform for biopharmaceuticals: present status and prospect.

Authors:  Jianfeng Xu; Ningning Zhang
Journal:  Pharm Bioprocess       Date:  2014-12-01

4.  Oral immunization of animals with transgenic cherry tomatillo expressing HBsAg.

Authors:  Yi Gao; Ying Ma; Mei Li; Tong Cheng; Shao-Wei Li; Jun Zhang; Ning-Shao Xia
Journal:  World J Gastroenterol       Date:  2003-05       Impact factor: 5.742

Review 5.  Plant-based oral vaccines: results of human trials.

Authors:  C O Tacket
Journal:  Curr Top Microbiol Immunol       Date:  2009       Impact factor: 4.291

6.  Virus-like particle production with yeast: ultrastructural and immunocytochemical insights into Pichia pastoris producing high levels of the hepatitis B surface antigen.

Authors:  Heinrich Lünsdorf; Chandrasekhar Gurramkonda; Ahmad Adnan; Navin Khanna; Ursula Rinas
Journal:  Microb Cell Fact       Date:  2011-06-26       Impact factor: 5.328

Review 7.  Putting the Spotlight Back on Plant Suspension Cultures.

Authors:  Rita B Santos; Rita Abranches; Rainer Fischer; Markus Sack; Tanja Holland
Journal:  Front Plant Sci       Date:  2016-03-11       Impact factor: 5.753

8.  Is it possible to ensure COVID19 vaccine supply by using plants?

Authors:  Anirban Bhar
Journal:  Nucleus (Calcutta)       Date:  2021-07-02

Review 9.  The twenty-year story of a plant-based vaccine against hepatitis B: stagnation or promising prospects?

Authors:  Tomasz Pniewski
Journal:  Int J Mol Sci       Date:  2013-01-21       Impact factor: 5.923

Review 10.  The Last Ten Years of Advancements in Plant-Derived Recombinant Vaccines against Hepatitis B.

Authors:  Young Hee Joung; Se Hee Park; Ki-Beom Moon; Jae-Heung Jeon; Hye-Sun Cho; Hyun-Soon Kim
Journal:  Int J Mol Sci       Date:  2016-10-13       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.